Results 271 to 280 of about 111,447 (309)

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Medicinal Research Reviews, Volume 46, Issue 1, Page 272-298, January 2026.
ABSTRACT Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders.
Baljinder Singh, Shubham Mahajan, Sadikalmahdi Abdella, Rehan Khan, Sanjay Garg   +4 more
wiley   +1 more source

Deciphering Pigmented Rice Varieties as Sustainable and Unexplored Valuable Sources of Bioactive Components With Health‐Related Properties and Technological Applications—A Systematic Review

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 1, January 2026.
ABSTRACT The interest in pigmented grains has grown substantially in recent years. Pigmented rice is crucial for diversifying agricultural production and promoting healthier, more balanced diets. This systematic review updates and discusses literature published between 2019 and 2024 on the bioactive compounds in pigmented rice, their potential health ...
Adolfo Pinheiro de Oliveira, Thatyane Mariano Rodrigues de Albuquerque, Evandro Leite de Souza   +2 more
wiley   +1 more source

Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 1, January 2026.
ABSTRACT Background Ephedrine, phenylephrine, and norepinephrine are commonly used to manage hypotension during the induction of anaesthesia. The objective of this study was to evaluate whether prophylactic administration of assumed equipotent doses of these vasopressors could maintain systolic arterial blood pressure (SAP) and heart rate (HR) within ...
Gunnar Helge Sjøen, Tor Hugo Hauge, Ragnhild Sørum Falk, Tor Inge Tønnessen, Eldrid Langesæter   +4 more
wiley   +1 more source

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 186-196, January 2026.
Abstract Aims To evaluate medication adherence in patients with type 2 diabetes (T2D) using plasma drug measurements and assess the clinical impact of partial non‐adherence on glycemic control and complications. Materials and Methods This cross‐sectional study included 641 T2D outpatients attending routine follow‐up visits.
Vojtěch Škop, Ivana Laňková, Simona Antalová, Iva Míšková, Kateřina Malá‐Ládová, Josef Malý, Terezie Pelikánová, Jiří Hricko, Tomáš Čajka, Martin Haluzík   +9 more
wiley   +1 more source

Risk of depression with GLP‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 197-209, January 2026.
Abstract Aims The association between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and depression remains uncertain due to contradictory evidence. We compared the risk of incident depression between GLP‐1 RAs and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) in overweight or obese adults with type 2 diabetes.
Yu Chang, Ming‐Hong Hsieh, Po‐Chung Ju, Cheng‐Chen Chang   +3 more
wiley   +1 more source

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 16-26, January 2026.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials. [PDF]

BMC Cardiovasc Disord
Wu J, Di H, Zhang Y, Zeng X.
europepmc   +1 more source

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 434-442, January 2026.
Abstract Aims Serum 1,5‐anhydroglucitol (1,5‐AG) indicates glycemic control over 1–2 weeks and is particularly useful for monitoring postprandial hyperglycemia. However, its predictive value for long‐term outcomes in type 2 diabetes has not been fully established.
Jiaying Ni, Lei Chen, Hang Su, Jinghao Cai, Chunfang Wang, Wei Lu, Yufei Wang, Jingyi Lu, Tian Xia, Jian Zhou   +9 more
wiley   +1 more source

Review on: Experimental Screening Methods for Antihypertensive Agents.

Mrunal K. Shirsat, Mrs. Shweta Bahire, Ms. Ashwini Dilip Patil, Ms. Vaibhavi.S. Bhosale   +3 more
openalex   +1 more source

Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 593-605, January 2026.
Abstract Aims Managing blood pressure (BP) in older adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) remains controversial, particularly regarding optimal targets and the impact of inadequate monitoring. Using Clinical Practice Research Datalink (CPRD) data, this study assessed associations between baseline systolic and diastolic BP ...
Anna Meffen, Freya Tyrer, Junior Mbah Mbahnjeck, Kamlesh Khunti, Francesco Zaccardi, Setor K. Kunutsor   +5 more
wiley   +1 more source